Cortisone acetate
Cortone (cortisone acetate) is a small molecule pharmaceutical. Cortisone acetate was first approved as Cortisone acetate on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis, ankylosing spondylitis, asthma, and atopic dermatitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| infections | D007239 |
| neoplasms | D009369 |
| musculoskeletal diseases | D009140 |
| digestive system diseases | D004066 |
| respiratory tract diseases | D012140 |
| otorhinolaryngologic diseases | D010038 |
| nervous system diseases | D009422 |
| eye diseases | D005128 |
| urogenital diseases | D000091642 |
| hemic and lymphatic diseases | D006425 |
Show 7 more
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cortisone acetate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTISONE ACETATE | Impax Laboratories | N-009458 DISCN | 1982-01-01 | 1 products |
| CORTONE | Merck KGaA | N-007110 DISCN | 1982-01-01 | 2 products |
| CORTONE | Merck KGaA | N-007750 DISCN | 1982-01-01 | 1 products, RLD |
| CORTISONE ACETATE | Panray Corporation | N-008284 DISCN | 1982-01-01 | 2 products |
| CORTISONE ACETATE | Pharmacia & Upjohn | N-008126 DISCN | 1982-01-01 | 4 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| adrenal insufficiency | — | D000309 | — |
| allergic rhinitis | — | D065631 | J30.9 |
| ankylosing spondylitis | EFO_0003898 | D013167 | M45 |
| asthma | EFO_0000270 | D001249 | J45 |
| atopic dermatitis | EFO_0000274 | D003876 | L20 |
| berylliosis | EFO_0007168 | D001607 | J63.2 |
| bursitis | EFO_1000941 | D002062 | M71.9 |
| choroiditis | — | D002833 | H30.9 |
| collagen diseases | — | D003095 | — |
| dermatitis herpetiformis | — | D003874 | L13.0 |
Show 19 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB10: Cortisone
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA03: Cortisone
HCPCS
Code | Description |
|---|---|
| J1700 | Injection, hydrocortisone acetate, up to 25 mg |
Clinical
Clinical Trials
70 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 9 | 7 | — | — | — | 11 |
| Large b-cell lymphoma diffuse | D016403 | C83.3 | 4 | 5 | — | — | — | 8 | |
| Neoplasms | D009369 | C80 | 7 | 1 | — | — | — | 7 | |
| Follicular lymphoma | D008224 | C82 | 2 | 3 | — | — | — | 5 | |
| B-cell chronic lymphocytic leukemia | D015451 | C91.1 | 2 | 2 | — | — | — | 4 | |
| Endometrial neoplasms | D016889 | EFO_0004230 | 1 | 3 | — | — | — | 4 | |
| Multiple myeloma | D009101 | C90.0 | 1 | 2 | — | — | — | 3 | |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 2 | — | — | — | 3 |
| Lymphoma | D008223 | C85.9 | 1 | 2 | — | — | — | 3 | |
| Endometrioid carcinoma | D018269 | 1 | 2 | — | — | — | 3 |
Show 29 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 2 | — | — | — | — | 2 | |
| Hodgkin disease | D006689 | C81 | 2 | — | — | — | — | 2 | |
| Healthy volunteers/patients | — | 2 | — | — | — | — | 2 | ||
| Non-small-cell lung carcinoma | D002289 | 2 | — | — | — | — | 2 | ||
| Myelodysplastic syndromes | D009190 | D46 | 1 | — | — | — | — | 1 | |
| Myeloid leukemia acute | D015470 | C92.0 | 1 | — | — | — | — | 1 | |
| Hematologic neoplasms | D019337 | 1 | — | — | — | — | 1 | ||
| Primary myelofibrosis | D055728 | D47.4 | 1 | — | — | — | — | 1 | |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 1 | — | — | — | — | 1 | |
| Myelomonocytic leukemia chronic | D015477 | C93.1 | 1 | — | — | — | — | 1 |
Show 16 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CORTISONE ACETATE |
| INN | cortisone |
| Description | Cortisone acetate is a corticosteroid hormone. |
| Classification | Small molecule |
| Drug class | Corticosteroid; Glucocorticoid |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 50-04-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1650 |
| ChEBI ID | 3897 |
| PubChem CID | 5745 |
| DrugBank | DB01380 |
| UNII ID | V27W9254FZ (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 26,298 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
229 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more